Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meta Roestenberg

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Bioethics|August 27, 2020
Judging the social value of controlled human infection studiesAnnette Rid, Meta Roestenberg
BMJ Open|July 28, 2020
Money-oriented risk-takers or deliberate decision-makers: a cross-sectional survey study of participants in controlled human infection trialsMarie-Astrid Hoogerwerf, Martine de Vries, Meta Roestenberg
Nature Reviews. Immunology|December 24, 2010
Experimental human challenge infections can accelerate clinical malaria vaccine developmentRobert W Sauerwein, Meta Roestenberg, Vasee S Moorthy
Expert Review of Vaccines|July 6, 2021
Controlled human infection models to evaluate schistosomiasis and hookworm vaccines: where are we now?Jan Pieter R Koopman, Emmanuella Driciru, Meta Roestenberg
The Lancet. Infectious Diseases|March 7, 2020
Are placebo controls necessary in controlled human infection trials for vaccines?Marijke C C Langenberg, Olaf M Dekkers, Meta Roestenberg
Vaccine|November 23, 2017
Controlled human infections: A report from the controlled human infection models workshop, Leiden University Medical Centre 4-6 May 2016Meta Roestenberg, Annie Mo, Peter G Kremsner, et al.
The Lancet. Global Health|March 18, 2022
COVID-19 vaccine dose sparing: strategies to improve vaccine equity and pandemic preparednessGeert V T Roozen, Anna H E Roukens, Meta Roestenberg
Frontiers in Medicine|March 7, 2019
Corrigendum: Controlled Human Infections As a Tool to Reduce Uncertainty in Clinical Vaccine DevelopmentMeta Roestenberg, Ingrid M C Kamerling, Saco J de Visser
Frontiers in Medicine|November 14, 2018
Controlled Human Infections As a Tool to Reduce Uncertainty in Clinical Vaccine DevelopmentMeta Roestenberg, Ingrid M C Kamerling, Saco J de Visser
Plos Neglected Tropical Diseases|April 2, 2026
Advances in vaccine development through the controlled human infection models for hookworm and schistosomiasisMarie-Astrid Hoogerwerf, Moses Egesa, Selidgji Todagbe Agnandji, et al.
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Bioethics|August 27, 2020
Judging the social value of controlled human infection studiesAnnette Rid, Meta Roestenberg
BMJ Open|July 28, 2020
Money-oriented risk-takers or deliberate decision-makers: a cross-sectional survey study of participants in controlled human infection trialsMarie-Astrid Hoogerwerf, Martine de Vries, Meta Roestenberg
Nature Reviews. Immunology|December 24, 2010
Experimental human challenge infections can accelerate clinical malaria vaccine developmentRobert W Sauerwein, Meta Roestenberg, Vasee S Moorthy
Expert Review of Vaccines|July 6, 2021
Controlled human infection models to evaluate schistosomiasis and hookworm vaccines: where are we now?Jan Pieter R Koopman, Emmanuella Driciru, Meta Roestenberg
The Lancet. Infectious Diseases|March 7, 2020
Are placebo controls necessary in controlled human infection trials for vaccines?Marijke C C Langenberg, Olaf M Dekkers, Meta Roestenberg
Vaccine|November 23, 2017
Controlled human infections: A report from the controlled human infection models workshop, Leiden University Medical Centre 4-6 May 2016Meta Roestenberg, Annie Mo, Peter G Kremsner, et al.
The Lancet. Global Health|March 18, 2022
COVID-19 vaccine dose sparing: strategies to improve vaccine equity and pandemic preparednessGeert V T Roozen, Anna H E Roukens, Meta Roestenberg
Frontiers in Medicine|March 7, 2019
Corrigendum: Controlled Human Infections As a Tool to Reduce Uncertainty in Clinical Vaccine DevelopmentMeta Roestenberg, Ingrid M C Kamerling, Saco J de Visser
Frontiers in Medicine|November 14, 2018
Controlled Human Infections As a Tool to Reduce Uncertainty in Clinical Vaccine DevelopmentMeta Roestenberg, Ingrid M C Kamerling, Saco J de Visser
Plos Neglected Tropical Diseases|April 2, 2026
Advances in vaccine development through the controlled human infection models for hookworm and schistosomiasisMarie-Astrid Hoogerwerf, Moses Egesa, Selidgji Todagbe Agnandji, et al.
Pageof 13